Harvard Bioscience Inc (NASDAQ:HBIO)
| 5.67 Delayed Data As of Jun 05 |  -0.06 / -1.05%Today’s Change | 1.98 Today|||52-Week Range 6.29 | +104.69% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -19.0M | -4.3M | -865.0K | -2.9M | |
| Depreciation | 4.6M | 4.3M | 3.8M | 7.8M | ||
| Total Other Cash Flow | 2.8M | 5.7M | 3.5M | 2.5M | ||
| Funds From Operations | 3.4M | 5.4M | 4.9M | 4.6M | ||
| Funds From/For Other Operating Expenses | 2.7M | 41.0K | 3.8M | 1.7M | ||
| Net Cash Flow - Operating Activities | 705.0K | 5.4M | 1.1M | 2.9M | ||
| Investing | Capital Expenditures | -3.0M | -1.4M | -890.0K | -986.0K | |
| Fixed Asset Disposal | 6.0K | 1.4M | 12.0K | 15.8M | ||
| Net Assets From Acquisitions | -4.5M | 0.00 | 0.00 | -68.5M | ||
| Other Investing - Uses | -18.0K | 0.00 | 0.00 | 0.00 | ||
| Net Cash Flow Investing | -7.5M | -62.0K | -917.0K | -53.8M | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 5.8M | 4.0M | 2.8M | 68.7M | ||
| Long Term Debt Reduction | -8.4M | -9.1M | -4.7M | -20.2M | ||
| Net Proceeds Stock Sale | 2.0M | 182.0K | 160.0K | 4.6M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | -540.0K | -4.9M | -1.8M | 53.1M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -38.0K | -1.6M | 1.8M | 299.0K | |
| Net Change In Cash | -7.4M | 453.0K | -1.7M | 2.1M | ||
